5.0
22 Apr 2026
Current employee, more than 5 years
San Francisco, CA
Recommend
CEO approval
Business outlook
Pros
chance to make a bigger impact than at big pharma but not as risky as a small biotech or start up where the company can run out of funding, high pay, flexible hours
Cons
longer work hours, off-hour calls with different regions depending on the role, experiences can vary by group